diabetes

The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: The next CRISPR fight, cheaper insulin, & an FDA shuffle

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Eli Lilly cuts prices for some insulin products; congressional committee opens probe into PBMs

Pharmalot Matthew Herper and Ed Silverman

Eli Lilly cuts prices for some insulin products, but some are wary

Health Matthew Herper

One type of artificial sweetener may increase heart attack risk, preliminary study says

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Biden wants $35 insulin cap for all Americans; pharma loses a court case over importing drugs from Canada

Health Elaine Chen

STAT Plus: Mix-it-yourself Wegovy? Some are trying risky sources for weight-loss drugs

Biotech Jason Mast

STAT Plus: After four years of big talk, mega startup Sana prepares to deliver some data

Pharmalot Ed Silverman

STAT Plus: California is the latest state to sue drugmakers and PBMs over insulin pricing

Health Elaine Chen

Diabetes in youth is set to skyrocket in coming decades

First Opinion Robert Gabbay

To effectively combat diabetes, policymakers must treat obesity like other diseases

Health Elaine Chen

Diabetes treatments are improving. Racial disparities are wider than ever

Pharma Elaine Chen

STAT Plus: Eli Lilly diabetes drug Mounjaro in short supply, FDA says

The Readout LOUD Damian Garde, Allison DeAngelis and Adam Feuerstein

The ‘electric vehicles’ of pharma, Illumina’s boondoggle, & a Theranos sentencing

Health Elaine Chen

STAT Plus: Eli Lilly tightens access to diabetes drug, frustrating some people with obesity

Health Justin Chen

STAT Plus: Nectar bats are ‘wonderful, majestic’ and sugar-obsessed. This researcher wants to know how they stay healthy

Pharmalot Ed Silverman

STAT Plus: How many? A new analysis finds 1.3 million American adults rationed insulin due to cost

First Opinion Aaron J. Kowalski

The global diabetes crisis few are talking about

Pharmalot Ed Silverman

STAT Plus: ‘Patchy efforts’ by major insulin makers mean access lags in many poor countries

Health Tech Katie Palmer

STAT Plus: A bionic pancreas aims to take the math out of managing type 1 diabetes

Politics Rachel Cohrs

STAT Plus: Unpacking the drug pricing policies that Congress just approved

Matt's Take Matthew Herper

STAT Plus: The Senate’s drug pricing bill is an inevitable solution. It will still have plenty of unintended consequences

Politics Rachel Cohrs

In a massive victory for Democrats, Medicare is poised to negotiate drug prices

Health Tech Katie Palmer

STAT Plus: Patients seeking novel weight loss drugs find a ‘wild west’ of online prescribers

Health Edward Chen

As diabetes during pregnancy grows more common, experts point to a need for preventive care

Health Akila Muthukumar Valliammai

STAT Plus: Popular drug may have new benefit in men with diabetes, but not women, study shows

Health Tech Katie Palmer

STAT Plus: With new research, health tech companies try to make a case for virtual diabetes care

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Cancer coalition aims to boost access to meds in poor countries; Moderna’s vaccine patent defense poses shield for others

Biotech Matthew Herper

STAT Plus: FDA approves Lilly diabetes drug that analysts expect to be a big seller

Health Isabella Cueto

Black, Hispanic, and Asian Americans should be screened at lower BMI for diabetes, study says